Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

The proportion of incident cases of schizophrenia associated with cannabis use disorder (CUD) almost tripled from the p ...

A new cohort study has found that schizophrenia cases related to cannabis use heavy enough to warrant a person to seek ...

A new study from Canadian researchers has found that the proportion of new schizophrenia cases associated with cannabis use ...

A support group for carers of people with mental illnesses has led to "marvellous friendships", those involved have said. The ...

Resilience factors were associated with less severe positive and negative schizophrenia symptoms, suggesting resilience may play a protective role.

Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

Dr. Raheja has expanded psychiatric care through telepsychiatry, bringing services to rural Wisconsin at Thedacare Regional ...

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...

Insurance firms launch mental illness coverage amid rising treatment rates in Korea Insurance companies adapt to changing ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...